Poor predictive value of high-sensitivity C-reactive protein indicates need for reassessment

被引:23
作者
Levinson, SS
Miller, JJ
Elin, RJ
机构
[1] Dept Vet Affairs, Ctr Med, Lab Serv, Louisville, KY 40206 USA
[2] Univ Louisville, Sch Med, Dept Pathol & Lab Med, Louisville, KY USA
关键词
D O I
10.1373/clinchem.2004.037895
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:1733 / 1735
页数:3
相关论文
共 26 条
[1]  
*3 REP NCEP EXP PA, 2002, CIRCULATION, V106, P3145
[2]   Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].
Albert, MA ;
Danielson, E ;
Rifai, N ;
Ridker, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70
[3]   C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J].
Danesh, J ;
Wheeler, JG ;
Hirschfield, GM ;
Eda, S ;
Eiriksdottir, G ;
Rumley, A ;
Lowe, GDO ;
Pepys, MB ;
Gudnason, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1387-1397
[4]   Distribution and correlates of C-reactive protein concentrations among adult US women [J].
Ford, ES ;
Giles, WH ;
Mokdad, AH ;
Myers, GL .
CLINICAL CHEMISTRY, 2004, 50 (03) :574-581
[5]   Major risk factors as antecedents of fatal and nonfatal coronary heart disease events [J].
Greenland, P ;
Knoll, MD ;
Stamler, J ;
Neaton, JD ;
Dyer, AR ;
Garside, DB ;
Wilson, PW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (07) :891-897
[6]   Clinical Management of Metabolic Syndrome - Report of the American heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management [J].
Grundy, SM ;
Hansen, B ;
Smith, SC ;
Cleeman, JI ;
Kahn, RA .
CIRCULATION, 2004, 109 (04) :551-556
[7]   Emerging risk factors for atherosclerotic vascular disease - A critical review of the evidence [J].
Hackam, DG ;
Anand, SS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (07) :932-940
[8]   Fibrinogen is an antioxidant that protects β-lipoproteins at physiological concentrations in a cell free system [J].
Kaplan, IV ;
Attaelmannan, M ;
Levinson, SS .
ATHEROSCLEROSIS, 2001, 158 (02) :455-463
[9]   Prevalence of conventional risk factors in. patients with coronary heart disease [J].
Khot, UN ;
Khot, MB ;
Bajzer, CT ;
Sapp, SK ;
Ohman, EM ;
Brener, SJ ;
Ellis, SG ;
Lincoff, AM ;
Topol, EJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (07) :898-904
[10]  
Koenig W, 2001, CLIN CHEM, V47, P9